← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Kinarx, Llc
Rockville, MD
$2,399,931
Total funding
2
Grants
Funding over time
peak $1.4M · FY2020–21$2M$1.5M$1M$500K$0
'20
'21
Funding mix
By agency
NIH$2,399,931 · 2
By mechanism
R44$1,999,998 · 1
R41$399,933 · 1
Investigators at Kinarx, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Third line treatment of drug resistant FLT3-positive acute myeloid leukemia with a novel FLT3 kinase inhibitor$1,000,000
R44 · FY2020 · CA
Third line treatment of drug resistant FLT3-positive acute myeloid leukemia with a novel FLT3 kinase inhibitor$999,998
R44 · FY2021 · CA
Aminonaphthyridine compounds as potential therapeutics for lung and thyroid cancers$399,933
R41 · FY2020 · CA